Hydroxyurea utilization among individuals with sickle cell disease in Tennessee: a pooled analysis of claims data.
Saved in:
| Title: | Hydroxyurea utilization among individuals with sickle cell disease in Tennessee: a pooled analysis of claims data. |
|---|---|
| Authors: | Mukhopadhyay A; Division of Epidemiology, Biostatistics, and Environmental Health, School of Public Health, The University of Memphis, Memphis, TN, United States., Smeltzer MP; Division of Epidemiology, Biostatistics, and Environmental Health, School of Public Health, The University of Memphis, Memphis, TN, United States., Dudley J; Department of Health Policy, Vanderbilt University Medical Center, Nashville, TN, United States., Badawy SM; Division of Hematology, Oncology and Stem Cell Transplant, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, United States., Mathias JG; Department of Epidemiology, Gillings School of Public Health, University of North Carolina, Chapel Hill, NC, United States., Plaxco AP; Division of Epidemiology, Biostatistics, and Environmental Health, School of Public Health, The University of Memphis, Memphis, TN, United States., Ray MA; Division of Epidemiology, Biostatistics, and Environmental Health, School of Public Health, The University of Memphis, Memphis, TN, United States., Wiese AD; Department of Health Policy, Vanderbilt University Medical Center, Nashville, TN, United States., Stevens WI; Division of Epidemiology, Biostatistics, and Environmental Health, School of Public Health, The University of Memphis, Memphis, TN, United States., Gurney JG; Division of Epidemiology, Biostatistics, and Environmental Health, School of Public Health, The University of Memphis, Memphis, TN, United States., Nwosu C; Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN, United States., Porter JS; Department of Psychology, St. Jude Children's Research Hospital, Memphis, TN, United States., Klesges LM; Department of Surgery, Washington University School of Medicine, StLouis, MO, United States., Hankins JS; Departments of Global Pediatric Medicine and Hematology, St. Jude Children's Research Hospital, Memphis, TN, United States., Cooper WO; Center for Patient and Professional Advocacy, Vanderbilt University Medical Center, Nashville, TN, United States. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2025 Dec 19; Vol. 16, pp. 1693126. Date of Electronic Publication: 2025 Dec 19 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1663-9812 |
|---|---|
| DOI: | 10.3389/fphar.2025.1693126 |
